MDPI and ACS Style
Pochtovyi, A.A.; Kustova, D.D.; Siniavin, A.E.; Dolzhikova, I.V.; Shidlovskaya, E.V.; Shpakova, O.G.; Vasilchenko, L.A.; Glavatskaya, A.A.; Kuznetsova, N.A.; Iliukhina, A.A.;
et al. In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1. Vaccines 2023, 11, 1533.
https://doi.org/10.3390/vaccines11101533
AMA Style
Pochtovyi AA, Kustova DD, Siniavin AE, Dolzhikova IV, Shidlovskaya EV, Shpakova OG, Vasilchenko LA, Glavatskaya AA, Kuznetsova NA, Iliukhina AA,
et al. In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1. Vaccines. 2023; 11(10):1533.
https://doi.org/10.3390/vaccines11101533
Chicago/Turabian Style
Pochtovyi, Andrei A., Daria D. Kustova, Andrei E. Siniavin, Inna V. Dolzhikova, Elena V. Shidlovskaya, Olga G. Shpakova, Lyudmila A. Vasilchenko, Arina A. Glavatskaya, Nadezhda A. Kuznetsova, Anna A. Iliukhina,
and et al. 2023. "In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1" Vaccines 11, no. 10: 1533.
https://doi.org/10.3390/vaccines11101533
